Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.84 INR | +4.03% |
|
+5.58% | -6.89% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 30.04 | 18.77 | 6.257 | 28.47 | 153.3 | 108.3 |
Enterprise Value (EV) 1 | -119.9 | -145.4 | -160.6 | -152.4 | -24.06 | -24.39 |
P/E ratio | 24 x | 69.8 x | 26.3 x | 41 x | 110 x | 67.8 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.04 x | 1.07 x | 0.31 x | 0.92 x | 8.32 x | 2.72 x |
EV / Revenue | -4.14 x | -8.31 x | -8.04 x | -4.94 x | -1.31 x | -0.61 x |
EV / EBITDA | -66.2 x | -359 x | - | - | - | - |
EV / FCF | -26.4 x | -10.3 x | -60.5 x | -11 x | 5.49 x | 0.54 x |
FCF Yield | -3.79% | -9.72% | -1.65% | -9.11% | 18.2% | 185% |
Price to Book | 0.1 x | 0.06 x | 0.02 x | 0.09 x | 0.49 x | 0.35 x |
Nbr of stocks (in thousands) | 31,287 | 31,287 | 31,287 | 31,287 | 31,287 | 31,287 |
Reference price 2 | 0.9600 | 0.6000 | 0.2000 | 0.9100 | 4.900 | 3.460 |
Announcement Date | 19-02-22 | 19-09-24 | 20-10-07 | 21-09-07 | 22-09-08 | 23-09-07 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 28.95 | 17.5 | 19.97 | 30.88 | 18.43 | 39.83 |
EBITDA 1 | 1.81 | 0.405 | - | - | - | - |
EBIT 1 | 1.773 | 0.3682 | 0.317 | 0.9396 | 1.878 | 2.001 |
Operating Margin | 6.12% | 2.1% | 1.59% | 3.04% | 10.19% | 5.02% |
Earnings before Tax (EBT) 1 | 1.773 | 0.3669 | 0.3169 | 0.9378 | 1.877 | 2.155 |
Net income 1 | 1.317 | 0.2691 | 0.2376 | 0.6939 | 1.389 | 1.591 |
Net margin | 4.55% | 1.54% | 1.19% | 2.25% | 7.54% | 3.99% |
EPS 2 | 0.0400 | 0.008601 | 0.007592 | 0.0222 | 0.0444 | 0.0510 |
Free Cash Flow 1 | 4.548 | 14.14 | 2.656 | 13.88 | -4.383 | -45.04 |
FCF margin | 15.71% | 80.79% | 13.3% | 44.95% | -23.78% | -113.08% |
FCF Conversion (EBITDA) | 251.28% | 3,490.73% | - | - | - | - |
FCF Conversion (Net income) | 345.45% | 5,252.95% | 1,118.26% | 2,000.06% | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 19-02-22 | 19-09-24 | 20-10-07 | 21-09-07 | 22-09-08 | 23-09-07 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 150 | 164 | 167 | 181 | 177 | 133 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 4.55 | 14.1 | 2.66 | 13.9 | -4.38 | -45 |
ROE (net income / shareholders' equity) | 0.43% | 0.09% | 0.08% | 0.22% | 0.45% | 0.51% |
ROA (Net income/ Total Assets) | 0.34% | 0.07% | 0.06% | 0.18% | 0.36% | 0.39% |
Assets 1 | 382.4 | 387.8 | 394.6 | 385.5 | 384.9 | 410.8 |
Book Value Per Share 2 | 9.860 | 9.870 | 9.870 | 9.900 | 9.960 | 10.00 |
Cash Flow per Share 2 | 0.0800 | 0.0400 | 0 | 0.0500 | 0.0600 | 0.1700 |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 19-02-22 | 19-09-24 | 20-10-07 | 21-09-07 | 22-09-08 | 23-09-07 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-6.89% | 1.02M | |
+43.81% | 997M | |
-27.67% | 846M | |
-12.77% | 417M | |
+14.19% | 376M | |
+45.75% | 423M | |
-23.13% | 363M | |
-6.63% | 269M | |
-46.63% | 237M | |
-47.22% | 232M |
- Stock Market
- Equities
- SYMBIOX6 Stock
- Financials Symbiox Investment & Trading Co Ltd